These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36553500)

  • 1. Bioinformatics Prediction and Machine Learning on Gene Expression Data Identifies Novel Gene Candidates in Gastric Cancer.
    Kori M; Gov E
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.
    Sinnarasan VSP; Paul D; Das R; Venkatesan A
    OMICS; 2023 Jun; 27(6):260-272. PubMed ID: 37229622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer.
    Matsuoka T; Yashiro M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
    Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
    Liu SS; Wan QS; Lv C; Wang JK; Jiang S; Cai D; Liu MS; Wang T; Zhang KH
    BMC Cancer; 2024 Apr; 24(1):465. PubMed ID: 38622522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
    Zhao X; Wu S; Jing J
    Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of
    Wang MQ; Yin QY; Chen YR; Zhu SL
    Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
    Li S; Yu C; Cheng Y; Du F; Wen G
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forecasting Gastric Cancer Diagnosis, Prognosis, and Drug Repurposing with Novel Gene Expression Signatures.
    Demirtas TY; Rahman MR; Yurtsever MC; Gov E
    OMICS; 2022 Jan; 26(1):64-74. PubMed ID: 34910889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic marker identification based on weighted gene co-expression network analysis and associated
    Guo H; Yang J; Liu S; Qin T; Zhao Q; Hou X; Ren L
    Bioengineered; 2021 Dec; 12(1):4666-4680. PubMed ID: 34338150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
    Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
    BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
    Zhu YZ; Liu Y; Liao XW; Luo SS
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
    Zhang X; Jiang Y; Xie Y; Leng X; Song F
    DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.
    Xie N; Bai Y; Qiao L; Bai Y; Wu J; Li Y; Jiang M; Xu B; Ni Z; Yuan T; Shi Y; Wu K; Xu F; Wang J; Dong L; Liu N
    J Cell Mol Med; 2021 Apr; 25(8):4014-4027. PubMed ID: 33724652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.